Vol. 11 No. 2 (2010)

Vol. 11 No. 2 (2010)

Published: 2010-06-15

Equity of access to innovative drugs and sustainability of pharmaceutical expenditure

Mario Eandi

53-54
- PDF

Fungal infections today: size of the problem and focus on the initial cost of therapy with echinocandin

Mario Venditti

55-62
- PDF
Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept

Viola Sacchi, Orietta Zaniolo, Ignazio Olivieri

63-76
- PDF
Cost/effectiveness analysis of atorvastatin in patients with acute coronary syndromes

Simona Cammarota, Enrica Menditto, Daria Putignano, Anna Citarella

83-89
- PDF
Economic evaluation of the use of saxagliptin in the treatment of type 2 diabetes in Italy

Marco Cristiani, Anna Citarella, Andrea Belisari, Guido Didoni, Lorenzo Giovanni Mantovani, Sabato Montella

103-115
- PDF
Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy

Orietta Zaniolo, Sorrel E. Wolowacz, Lorenzo Pradelli

91-101
- PDF

Ipertensione arteriosa polmonare: stima della casistica italiana e considerazioni sull’impatto sul budget dell’introduzione di tadalafil

Luca Guidi, Mariano Alejandro Mignini

77-82
- PDF